All In Biotech

Drug Trial Radar · NCT05608876

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

A Phase II, Open Label, Single Arm Study To Assess The Efficacy Of Intratumoral Tigilanol Tiglate In Various Head And Neck Solid Malignancies

Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

15

Actual

Start

Nov 3, 2022

Primary completion

Jul 31, 2025

Study completion Aug 2026

Sponsor

Lead sponsor
QBiotics Group LimitedIndustry
Sponsor type
Industry
First posted
Nov 8, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase II, open label, single arm study to assess the efficacy of intratumoural tigilanol tiglate in various head and neck solid malignancies.

Conditions

  • Head and Neck Cancer

Interventions

  • Tigilanol TiglateDrug

    Tigilanol tiglate is a novel, short-chain diterpene ester in clinical development for intratumoural treatment of a wide range of solid tumours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tumour ResponseTime frame: 72 weeks

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • The Kinghorn Cancer Centre

    Sydney, New South Wales, Australia

  • Metro South Hospital and Health Service, via the Princess Alexandra Hospital

    Brisbane, Queensland, Australia

  • The Royal Marsden NHS Foundation Trust

    London, United Kingdom

  • Guy's and St Thomas' NHS Foundation Trust

    London, United Kingdom

  • Cardiff and Vale University Health Board - University Hospital of Wales (UHW)

    Cardiff, Cardiff, United Kingdom

  • East and North Hertfordshire NHS Trust (Incorporating Mount Vernon Cancer Centre) of Lister Hospital

    Stevenage, Hertfordshire, United Kingdom

  • The Clatterbridge Cancer Centre NHS Foundation Trust

    Bebington, Wirral, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.